Market Research Logo

Respiratory Care Devices Global Market - Forecast to 2026

Respiratory Care Devices Global Market - Forecast to 2026

Respiratory diseases such as asthma, chronic obstructive pulmonary diseases (COPD), sleep apnea and others are increasing due to tobacco smoking, second-hand smoking, vehicular smoke emissions, urbanization, industrializations and changing lifestyle. To control these conditions the usage of respiratory devices are rising. The Respiratory care device is one of the parts of medical device which is used for diagnosis, treatment and monitoring purpose. The respiratory care device global market is segmented based on the products, applications, end-users, and geography. Globally respiratory care devices market is showing rapid growth and also in coming years continuing to evolve in the field of research, development, and manufacturing due to its wide range of driving factors such as the increase in the incidence of respiratory diseases, rising use of non-invasive respiratory care devices and growing demand for homecare respiratory devices.

According to IQ4I analysis, the respiratory care devices global market is expected to grow at high single digit CAGR from 2019 to 2026 to reach $23,510.9 million by 2026. Respiratory care devices products market is segmented as diagnostic, therapeutic, monitoring devices, and consumables. The therapeutic devices market commanded the largest share in 2019, and the market is expected to grow at a strong single digit CAGR from 2019 to 2026.

The therapeutic devices product market is segmented into humidifiers, nebulizers, oxygen concentrators, PAP devices, resuscitators, ventilators, inhalers and others. According to IQ4I analysis, among therapeutic devices segment, ventilators commanded the largest revenue in 2019, the market is expected to grow at a mid single digit CAGR from 2019 to 2026. The PAP devices are expected to grow at a strong double digit CAGR from 2019 to 2026. The monitoring devices market is expected to grow at a mid single digit CAGR from 2019 to 2026. The monitoring devices are segmented into pulse oximeter, capnographs and gas analyzers. The pulse oximeters commanded the largest revenue in 2019 and the capnographs are expected to grow at a strong single digit CAGR from 2019 to 2026. The diagnostic devices are expected to grow at a mid single digit CAGR from 2019 to 2026. The diagnostic devices are segmented into spirometers, peak flow meters and polysomnographs, among these, spirometers commanded the largest share in 2019, peak flow meters are expected to grow at a single digit CAGR from 2019 to 2026. The consumables market is expected to grow at a single digit CAGR from 2019 to 2026. The consumables are segmented based on product into masks, nasal cannula, treachostomy devices and others. Mask commanded the largest revenue is expected to grow at a high single digit CAGR from 2019 to 2026.

The respiratory care devices market based on application is segmented into obstructive, restrictive, vascular, infectious and other respiratory conditions. Among applications, obstructive respiratory conditions commanded the largest revenue in 2019. The market is expected to grow at a high single digit CAGR from 2019 to 2026. The obstructive respiratory conditions are further segmented into COPD (chronic broinchitis and emphysema), asthma, cystic fibrosis, and obstructive sleep apnea, the COPD commanded the largest share of the market in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2026.

The end-users market is segmented into hospitals, home care and ambulatory surgical centers, among them, hospital care settings commanded the largest revenue in 2019. Globally, admission to emergency care is increasing due to respiratory disorder burdens and majorly respiratory therapists are treating more number of patients in these care settings. The Homecare setting is expected to grow at a strong single digit CAGR from 2019 to 2026. Respiratory home healthcare has opened new opportunities for the respiratory care devices market. The convenient and comfort at homecare environment, cost of the devices, rental respiratory devices, oxygen resupply systems and other factors shifting the hospital care environment to homecare environment. The hospital end-user segment is further sub-segmented based on care settings into emergency care, critical care/ICU, acute care, sleep center and others. The critical care segment commanded the largest revenue in 2019. The sleep centers are expected to grow at strong single digit CAGR from 2019 to 2026.

The geographic market is segmented into North America, Europe, Asia-Pacific and Rest of the World. Among these, North-America commanded the largest revenue in 2019. The market is expected to grow at a high single digit CAGR from 2019 to 2026 due to advancements in technology, demand for a respiratory disorder, healthcare expenditures by government reforms, and availability of skilled labors. Asia-Pacific is expected to grow at a strong double digit CAGR from 2019 to 2026. Asia-Pacific tends to be fastest-growing segment due to increase in investments in the healthcare sector and emerging economies which creates new opportunities. The other factors influencing are incorporating new technologies, growing health awareness, expansion in healthcare industry, fast economic growth, increasing aging populations, High prevalence of tobacco smoking, Increasing medical expenditure, and health awareness improvements.


1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 REPORT SCOPE
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET CRACKDOWN AND DATATRIANGULATION
2.6.3 SECONDARY SOURCES
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.4 MARKET DYNAMICS
3.4.1 DRIVERS AND OPPORTUNITIES
3.4.1.1 Rising incidences of respiratory diseases due to urbanization and air pollution
3.4.1.2 Increasing tobacco usage
3.4.1.3 Rising use of non-invasive respiratory care devices
3.4.1.4 Growing demand for home care respiratory devices
3.4.1.5 Advancements of technology
3.4.1.6 A huge pool of undiagnosed patients
3.4.1.7 Favorable reimbursement scenario
3.4.2 RESTRAINTS AND THREATS
3.4.2.1 Product recalls
3.4.2.2 Harmful effects of certain devices on neonates
3.4.2.3 Availability of low-cost products from local manufacturers
3.4.2.4 Stringent regulatory policies
3.4.2.5 Lack of awareness of the disease
3.5 REGULATORY AFFAIRS
3.5.1 U.S.
3.5.2 EUROPE
3.5.3 INDIA
3.5.4 CHINA
3.5.5 JAPAN
3.5.6 ISO STANDARDS
3.6 PORTER’S FIVE FORCE ANALYSIS
3.6.1 THREAT OF NEW ENTRANTS
3.6.2 THREAT OF SUBSTITUTES
3.6.3 COMPETITIVE RIVALRY
3.6.4 BARGAINING POWER OF SUPPLIERS
3.6.5 BARGAINING POWER OF BUYERS
3.7 MARKET SHARE ANALYSIS
3.7.1 RESPIRATORY CARE DEVICES GLOBAL MARKET SHARE
3.7.2 VENTILATOR GLOBAL MARKET SHARE ANALYSIS
3.7.3 PAP GLOBAL MARKET SHARE ANALYSIS
3.7.4 CPAP GLOBAL MARKET SHARE ANALYSIS
3.7.5 APAP GLOBAL MARKET SHARE ANALYSIS
3.7.6 BPAP GLOBAL MARKET SHARE ANALYSIS
3.8 OTHER SUPPORTIVE RESPIRATORY DEVICES
3.8.1 SNORING DEVICE
3.8.2 NEUROMODULATION-BREATHING DISORDER
(OBSTRUCTIVE SLEEP APNEA)
3.9 REIMBURSEMENT SCENARIO
3.10 TECHNOLOGICAL ADVANCEMENTS
3.10.1 INTEGRATED DEVICES
3.10.2 REMOTE MONITORING
3.10.3 MOBILE OXYGEN CONCENTRATOR
3.10.4 MINIATURIZATION
3.10.5 WIRELESS TECHNOLOGY
3.10.6 WEARABLE TECHNOLOGY
3.10.7 HYPERSONIC NEBULIZER
3.10.8 DIGITAL TECHNOLOGIES IN RESPIRATORY DEVICES
3.11 UPCOMING TECHNOLOGY
3.12 FUNDING SCENARIO
3.13 RESPIRATORY CARE DEVICES - DEALS
3.14 PRODUCT LAUNCH, APPROVALS AND PATENT GRANTS
3.15 CLINICAL TRIALS
3.16 SUPPLY CHAIN ANALYSIS
4 RESPIRATORY CARE DEVICES GLOBAL MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 THERAPEUTIC RESPIRATORY CARE DEVICES
4.2.1 HUMIDIFIERS
4.2.1.1 Active Humidifiers
4.2.1.2 Passive Humidifiers
4.2.2 NEBULIZERS
4.2.2.1 Jet Nebulizer
4.2.2.2 Ultrasonic Nebulizer
4.2.2.3 Mesh Nebulizer
4.2.2.4 Smart Nebulizer
4.2.3 OXYGEN CONCENTRATORS
4.2.3.1 Stationary Oxygen Concentrators
4.2.3.2 Portable Oxygen Concentrators
4.2.4 POSITIVE AIRWAY PRESSURE DEVICES (PAP)
4.2.4.1 Continuous PAP Devices (CPAP)
4.2.4.2 Automatic PAP (APAP) Devices
4.2.4.3 Bi-Level PAP (BPAP) Devices
4.2.5 RESUSCITATORS
4.2.5.1 Manual Resuscitator
4.2.5.2 Gas Powered Resuscitator
4.2.6 VENTILATORS
4.2.6.1 Non-Invasive Ventilators
4.2.6.2 Invasive Ventilators
4.2.7 VENTILATOR MARKET BY END-USERS
4.2.8 INHALERS
4.2.8.1 Dry Powder Inhalers
4.2.8.2 Metered Dose Inhaler
4.2.8.3 Soft Mist Inhaler
4.2.9 OTHERS
4.3 MONITORING RESPIRATORY CARE DEVICES
4.3.1 PULSE OXIMETERS
4.3.1.1 Finger Pulse Oximeters
4.3.1.2 Handheld Pulse Oximeters
4.3.1.3 Wrist Pulse Oximeters
4.3.1.4 Tabletop Pulse Oximeters
4.3.2 CAPNOGRAPHS
4.3.3 GAS ANALYZERS
4.4 DIAGNOSTIC RESPIRATORY CARE DEVICES
4.4.1 SPIROMETERS
4.4.1.1 Volumetric Spirometers
4.4.1.2 Flow Measuring Spirometers
4.4.2 PEAK FLOW METERS
4.4.3 POLYSOMNOGRAPH DEVICES (PSG)
4.4.3.1 Clinical Polysomnography Devices
4.4.3.2 Ambulatory Polysomnography Devices
4.5 CONSUMABLES
4.5.1 MASKS
4.5.1.1 Nasal Masks
4.5.1.2 Full Face Mask
4.5.1.3 Nasal Pillow Masks
4.5.1.4 Other Masks
4.5.2 TRACHEOSTOMY TUBE
4.5.3 NASAL CANNULAS
4.5.4 OTHER CONSUMABLES
5 RESPIRATORY CARE DEVICES MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 OBSTRUCTIVE RESPIRATORY CONDITION
5.2.1 ASTHMA
5.2.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
5.2.2.1 Chronic Bronchitis
5.2.2.2 Emphysema
5.2.3 CYSTIC FIBROSIS
5.2.4 OBSTRUCTIVE SLEEP APNEA (OSA)
5.3 RESTRICTIVE RESPIRATORY CONDITION
5.3.1 ARDS
5.3.2 LUNG CANCER
5.3.3 RESTRECTIVE LUNG DISEASES
5.3.4 OTHERS
5.4 VASCULAR DISEASES
5.4.1 PULMONARY FIBROSIS
5.4.2 PULMONARY HYPERTENSION (PH)
5.4.3 PULMONARY EDEMA
5.5 INFECTIOUS RESPIRATORY CONDITION
5.5.1 PNEUMONIA
5.5.2 TUBERCULOSIS
5.6 OTHERS
6 RESPIRATORY CARE DEVICES GLOBAL MARKETY, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.2.1 EMERGENCY CARE
6.2.2 CRITICAL CARE/INTENSIVE CARE UNIT (ICU)
6.2.3 ACUTE CARE
6.2.4 SLEEP CENTER UNIT
6.2.5 OTHER HOSPITAL CARE SETTINGS (OPD)
6.3 HOME HEALTH CARE
6.4 AMBULATORY SURGICAL CENTERS
7 REGIONAL MARKET ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 UNITED STATES (U.S.)
7.2.2 REST OF NORTH AMERICA
7.3 EUROPE
7.3.1 GERMANY
7.3.2 THE U.K.
7.3.3 FRANCE
7.3.4 REST OF EUROPE
7.4 ASIA-PACIFIC
7.4.1 JAPAN
7.4.2 CHINA
7.4.3 INDIA
7.4.4 REST OF APAC
7.5 REST OF THE WORLD
7.5.1 BRAZIL
7.5.2 REST OF LATIN AMERICA
7.5.3 MIDDLE EAST AND OTHER COUNTRIES
8 COMPANY DEVELOPMENTS
8.1 INTRODUCTION
8.2 NEW PRODUCT LAUNCHES
8.3 APPROVALS
8.4 ACQUISITIONS
8.5 AGREEMENTS
8.6 OTHERS
9 MAJOR COMPANIES
9.1 DRAGERWERK AG & CO. KGAA
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 FISHER AND PAYKEL HEALTHCARE CORPORATION LIMITED
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 GE HEALTHCARE
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 GETINGE GROUPS (MAQUET GMBH & CO. KG)
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 INOGEN, INC.
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 MASIMO CORPORATION
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 MEDTRONIC, PLC
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 PHILIPS N.V.
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 RESMED INC.
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 VYAIRE MEDICAL, INC
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
LIST OF TABLES
TABLE 1 RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 2 RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
TABLE 3 THERAPEUTIC RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 4 THERAPEUTIC RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 5 HUMIDIFIER GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 6 HUMIDIFIER GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 7 ACTIVE HUMIDIFIERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 8 PASSIVE HUMIDIFIERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 9 NEBULIZERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 10 NEBULIZERS GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 11 JET NEBULIZERS GLOBAL MARKET REVENUE, BY REGION(2018-2026) ($MN)
TABLE 12 ULTRASONIC NEBULIZER GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 13 MESH NEBULIZERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 14 SMART NEBULIZERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 15 OXYGEN CONCENTRATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 16 OXYGEN CONCENTRATORS GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 17 STATIONARY OXYGEN CONCENTRATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 18 PORTABLE OXYGEN CONCENTRATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 19 POSITIVE AIRWAY PRESSURE DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 20 POSITIVE AIRWAY PRESSURE DEVICES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 21 CONTINUOUS PAP DEVICES (CPAP) GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 22 CONTINUOUS PAP DEVICES (CPAP) NUMBER OF UNITS SOLD, BY REGION (2018-2026) (NO’S)
TABLE 23 AUTOMATIC PAP (APAP) DEVICES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 24 AUTOMATIC PAP DEVICES (APAP) NUMBER OF UNITS SOLD, BY REGION (2018-2026) (NO’S)
TABLE 25 BI-LEVEL PAP (BPAP) DEVICES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 26 BI-LEVEL PAP DEVICES (BPAP) NUMBER OF UNITS SOLD, BY REGION (2018-2026) (NO’S)
TABLE 27 RESUSCITATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 28 RESUSCITATORS GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 29 MANUAL RESUSCITATOR GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 30 GAS POWERED RESUSCITATOR GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 31 VENTILATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 32 VENTILATORS GLOBAL MARKET REVENUE, BY INTERPHASE, (2018-2026) ($MN)
TABLE 33 NON-INVASIVE VENTILATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 34 INVASIVE VENTILATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 35 VENTILATORS GLOBAL MARKET REVENUE, BY END-USERS,(2018-2026) ($MN)
TABLE 36 EMERGENCY CARE VENTILATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 37 CRITICAL CARE VENTILATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 38 ACUTE CARE VENTILATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 39 AMBULATORY VENTILATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 40 HOMECARE VENTILATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 41 INHALERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 42 INHALERS GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 43 DRY POWDER INHALERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 44 METERED DOSE INHALERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 45 SOFT MIST INHALER DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 46 OTHER THERAPEUTIC DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 47 MONITORING RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 48 MONITORING RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 49 PULSE OXIMETERS GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 50 FINGER PULSE OXIMETERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 51 HANDHELD PULSE OXIMETERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 52 WRIST PULSE OXIMETERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 53 TABLETOP PULSE OXIMETERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 54 CAPNOGRAPHS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 55 GAS ANALYZERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 56 DIAGNOSTIC RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 57 DIAGNOSTIC RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 58 SPIROMETERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 59 SPIROMETERS GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 60 VOLUMETRIC SPIROMETERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 61 FLOW MEASURING SPIROMETERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 62 PEAK FLOW METER GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
TABLE 63 POLYSOMNOGRAPH DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 64 POLYSOMNOGRAPH DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 65 CLINICAL POLYSOMNOGRAPH DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 66 AMBULATORY POLYSOMNOGRAPHS DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 67 CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 68 CONSUMABLES GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 69 MASKS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 70 MASKS GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 71 NASAL MASKS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 72 FUL FACE MASKS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 73 NASAL PILLOW MASKS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 74 OTHER MASKS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 75 TRACHEOSTOMY TUBE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 76 NASAL CANNULAS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 77 OTHER CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 78 RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 79 OBSTRUCTIVE RESPIRATORY CONDITION GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 80 OBSTRUCTIVE RESPIRATORY CONDITION GLOBAL MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 81 ASTHMA GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 82 COPD GLOBAL MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 83 COPD GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 84 CHRONIC BRONCHITIS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 85 EMPHYSEMA GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 86 CYSTIC FIBROSIS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 87 OBSTRUCTIVE SLEEP APNEA GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 88 RESTRICTIVE RESPIRATORY CONDITION GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 89 RESTRICTIVE RESPIRATORY CONDITION GLOBAL MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 90 ARDS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 91 LUNG CANCER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 92 RESTRICTIVE LUNG DISEASES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 93 OTHERS RESTRICTIVE RESPIRATORY CONDITION GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 94 VASCULAR DISEASES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 95 VASCULAR DISEASES GLOBAL MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 96 PULMONARY FIBROSIS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 97 PULMONARY HYPERTENSION GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 98 PULMONARY EDEMA GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 99 INFECTIOUS RESPIRATORY CONDITION GLOBAL MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 100 INFECTIOUS RESPIRATORY CONDITION GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 101 PNEUMONIA GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 102 TUBERCULOSIS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 103 OTHER RESPIRATORY APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 104 RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 105 HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 106 HOSPITALS GLOBAL MARKET REVENUE, BY CARE SETTING, (2018-2026) ($MN)
TABLE 107 EMERGENCY CARE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 108 CRITICAL CARE/ICU GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 109 ACUTE CARE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 110 SLEEP CENTER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 111 OTHER HOSPITAL CARE SETTINGS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 112 HOME CARE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 113 AMBULATORY SURGICAL CENTERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 114 RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 115 NORTH AMERICA RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 116 NORTH AMERICA THERAPEUTIC RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 117 NORTH AMERICA HUMIDIFIER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 118 NORTH AMERICA OXYGEN CONCENTRATORS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 119 NORTH AMERICA POSITIVE AIRWAY PRESSURE MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 120 NORTH AMERICA RESUSCITATORS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 121 NORTH AMERICA VENTILATORS DEVICE MARKET REVENUE, BY INTERPHASE, (2018-2026) ($MN)
TABLE 122 NORTH AMERICA NEBULIZERS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 123 NORTH AMERICA INHALERS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 124 NORTH AMERICA VENTILATORS MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 125 NORTH AMERICA MONITORING RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 126 NORTH AMERICA PULSE OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 127 NORTH AMERICA DIAGNOSTIC RESPRATORY CARE DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 128 NORTH AMERICA SPIROMETERS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 129 NORTH AMERICA POLYSOMNOGRAPH DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 130 NORTH AMERICA CONSUMABLES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 131 NORTH AMERICA MASKS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 132 NORTH AMERICA RESPIRATORY CARE DEVICES MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 133 NORTH AMERICA OBSTRUCTIVE RESPIRATORY CONDITION MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 134 NORTH AMERICA COPD MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 135 NORTH AMERICA RESTRICTIVE RESPIRATORY CONDITION MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 136 NORTH AMERICA VASCULAR DISEASES MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 137 NORTH AMERICA INFECTIOUS RESPIRATORY CONDITION MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 138 NORTH AMERICA RESPIRATORY CARE DEVICES MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 139 NORTH AMERICA HOSPITAL MARKET REVENUE, BY CARE SETTINGS, (2018-2026) ($MN)
TABLE 140 NORTH AMERICA RESPIRATORY CARE DEVICES MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 141 EUROPE RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 142 EUROPE THERAPEUTIC RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 143 EUROPE HUMIDIFIER MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 144 EUROPE OXYGEN CONCENTRATORS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 145 EUROPE POSITIVE AIRWAY PRESSURE (PAP) MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 146 EUROPE RESUSCITATORS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 147 EUROPE VENTILATORS DEVICES MARKET REVENUE, BY INTERPHSE, (2018-2026) ($MN)
TABLE 148 EUROPE NEBULIZERS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 149 EUROPE INHALERS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 150 EUROPE VENTILATORS MARKET REVENUE, BY END-USERS, (2018-2026) ($MN)
TABLE 151 EUROPE MONITORING RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 152 EUROPE PULSE OXIMETER MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 153 EUROPE DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 154 EUROPE SPIROMETERS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 155 EUROPE POLYSOMNOGRAPH DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 156 EUROPE CONSUMABLES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 157 EUROPE MASKS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 158 EUROPE RESPIRATORY CARE DEVICES MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 159 EUROPE OBSTRUCTIVE RESPIRATORY CONDITION MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 160 EUROPE COPD MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 161 EUROPE RESTRICTIVE RESPIRATORY CONDITION MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 162 EUROPE VASCULAR DISEASES MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 163 EUROPE INFECTIOUS RESPIRATORY CONDITIONS MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 164 EUROPE RESPIRATORY CARE DEVICE MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 165 EUROPE HOSPITAL MARKET REVENUE, BY CARE SETTINGS, (2018-2026) ($MN)
TABLE 166 EUROPE ERESPIRATORY CARE DEVICES MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 167 APAC RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 168 APAC THERAPEUTIC RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 169 APAC HUMIDIFIER MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 170 APAC OXYGEN CONCENTRATORS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 171 APAC POSITIVE AIRWAY PRESSURE (PAP) MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 172 APAC RESUSCITATORS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 173 APAC VENTILATORS DEVICES MARKET REVENUE, BY INTERPHASE, (2018-2026) ($MN)
TABLE 174 APAC NEBULIZERS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 175 APAC INHALERS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 176 APAC VENTILATORS MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 177 APAC RESPIRATORY CARE MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 178 APAC PULSE OXIMETER MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 179 APAC DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 180 APAC SPIROMETERS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN) TABLE 181 APAC POLYSOMNOGRAPH DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 182 APAC CONSUMABLES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 183 APAC MASKS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 184 APAC RESPIRATORY CARE DEVICES MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 185 APAC OBSTRUCTIVE RESPIRATORY CONDITION MARKET REVENUE,BY APPLICATIONS, (2018-2026) ($MN)
TABLE 186 APAC COPD MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 187 APAC RESTRICTIVE RESPIRATORY CONDITION MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 188 APAC VASCULAR DISEASES MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 189 APAC INFECTIOUS RESPIRATORY MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 190 APAC RESPIRATORY CARE DEVICES MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 191 APAC HOSPITAL MARKET REVENUE, BY CARE SETTINGS, (2018-2026) ($MN)
TABLE 192 APAC RESPIRATORY CARE DEVICES MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 193 ROW RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 194 ROW THERAPEUTIC RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 195 ROW HUMIDIFIER MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 196 ROW OXYGEN CONCENTRATORS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 197 ROW POSITIVE AIRWAY PRESSURE DEVICES (PAP) MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 198 ROW RESUSCITATORS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 199 ROW VENTILATORS DEVICES MARKET REVENUE, BY INTERPHASE, (2018-2026) ($MN)
TABLE 200 ROW NEBULIZERS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 201 ROW INHALERS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 202 ROW VENTILATORS MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 203 ROW MONITORING RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 204 ROW PULSE OXIMETER MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 205 ROW DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 206 ROW SPIROMETERS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 207 ROW POLYSOMNOGRAPH DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 208 ROW CONSUMABLES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 209 ROW MASKS MARKET REVENUE, BY PRODUCTS, 2018-2026) ($MN)
TABLE 210 ROW RESPIRATORY CARE DEVICES MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 211 ROW OBSTRUCTIVE RESPIRATORY CONDITION MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 212 ROW COPD MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 213 ROW RESTRICTIVE RESPIRATORY CONDITION MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 214 ROW VASCULAR DISEASES MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 215 ROW INFECTIOUS RESPIRATORY MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 216 ROW RESPIRATORY CARE DEVICES MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 217 ROW HOSPITAL MARKET REVENUE, BY CARE SETTINGS, (2018-2026) ($MN)
TABLE 218 ROW RESPIRATORY CARE DEVICE MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 219 NEW PRODUCT LAUNCHES (2018-2019)
TABLE 220 APPROVALS (2018-2019)
TABLE 221 ACQUISITIONS (2018-2019)
TABLE 222 AGREEMENTS (2018-2019)
TABLE 223 OTHERS (2018-2019)
TABLE 224 DRAGERWERK AG & CO. KGAA TOTAL REVENUE AND R&D EXPENSES (2017-2019)(Q2) ($MN)
TABLE 225 DRAGERWERK AG & CO. KGAA: TOTAL REVENUE, BY SEGMENTS, (2017-2019)(Q2) ($MN)
TABLE 226 DRAGER MEDICAL AG & CO. KGAA: TOTAL REVENUE, BY GEOGRAPHY (2017-2019)(Q2) ($MN)
TABLE 227 FISHER AND PAYKEL TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
TABLE 228 FISHER AND PAYKEL TOTAL REVENUE, BY PRODUCTS, (2016-2018) ($MN)
TABLE 229 FISHER AND PAYKEL TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
TABLE 230 GE COMPANY (GE HEALTHCARE): TOTAL REVENUE AND R&D EXPENSES, (2017-2019)(Q2) ($MN)
TABLE 231 GE COMPANY (GE HEALTHCARE): TOTAL REVENUE, BY SEGMENTS, (2017-2019)(Q2) ($MN)
TABLE 232 GETINGE GROUPS: TOTAL REVENUE AND R&D EXPENSES, (2017-2019)(Q2) ($MN)
TABLE 233 GETINGE GROUPS: TOTAL REVENUE, BY SEGMENT, (2017-2019)(Q2) ($MN)
TABLE 234 GETINGE GROUPS: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019)(Q2) ($MN)
TABLE 235 INOGEN, INC. : TOTAL REVENUE AND R&D EXPENSES, (2017-2019)(Q2) ($MN)
TABLE 236 INOGEN, INC.: TOTAL REVENUE, BY REGION, (2017-2019)(Q2) ($MN)
TABLE 237 MASIMO CORPORATION : TOTAL REVENUE AND R&D EXPENSES, (2017-2019)(Q2) ($MN)
TABLE 238 MASIMO CORPORATION: TOTAL REVENUE, BY REGION, (2017-2019)(Q2) ($MN)
TABLE 239 MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
TABLE 240 MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENT, (2016-2018) ($MN)
TABLE 241 MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
TABLE 242 PHILIPS N.V.: TOTAL REVENUE AND R&D EXPENSES (2017-2019)(Q2) ($MN)
TABLE 243 PHILIPS N.V.: TOTAL REVENUE, BY SEGMENTS (2017-2019)Q2) ($MN)
TABLE 244 PHILIPS N.V.: TOTAL REVENUE, BY GEOGRAPHY (2017-2019)(Q2) ($MN)
TABLE 245 RESMED INC: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
TABLE 246 RESMED INC: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
LIST OF FIGURES
FIGURE 1 RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: RESPIRATORY CARE DEVICES GLOBAL MARKET
FIGURE 3 RESPIRATORY CARE DEVICES MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 RESPIRATORY CARE DEVICES GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 RESPIRATORY CARE DEVICES GLOBAL MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION
FIGURE 6 RESPIRATORY CARE DEVICES GLOBAL MARKET SEGMENTATION
FIGURE 7 MARKET DYNAMICS
FIGURE 8 RESPIRATORY CARE DEVICES GLOBAL MARKET: PORTER’S ANALYSIS
FIGURE 9 RESPIRATORY CARE DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2019) (%)
FIGURE 10 VENTILATOR GLOBAL MARKET SHARE, BY KEY PLAYERS (2019) (%)
FIGURE 11 PAP DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS, (2019) (%)
FIGURE 12 CPAP DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS, (2019) (%)
FIGURE 13 APAP DEVICES GLOBAL DEVICES MARKET SHARE, BY KEY PLAYERS, (2019) (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook